E. coli News and Research

RSS
E. coli or Escherichia coli is the name of a type of bacteria that lives in your intestines. Most types of E. coli are harmless. However, some types can make you sick and cause diarrhea. One type causes travelers' diarrhea. The worst type of E. coli causes bloody diarrhea, and can sometimes cause kidney failure and even death. These problems are most likely to occur in children and in adults with weak immune systems. You can get E. coli infections by eating foods containing the bacteria. To help avoid food poisoning and prevent infection, handle food safely. Cook meat well, wash fruits and vegetables before eating or cooking them, and avoid unpasteurized milk and juices. You can also get the infection by swallowing water in a swimming pool contaminated with human waste. Most cases of E. coli infection get better without treatment in 5 to 10 days.

Further Reading

TFAH urges U.S. Senate to reform the nation's food safety system without delay

TFAH urges U.S. Senate to reform the nation's food safety system without delay

AOAC Research Institute certifies Idaho's E.coli O157:H7 test

AOAC Research Institute certifies Idaho's E.coli O157:H7 test

Study shows students do not follow proper hygiene routines

Study shows students do not follow proper hygiene routines

Scarab Genomics releases new E. Coli strain

Scarab Genomics releases new E. Coli strain

Hygafem's hand sanitizing program launched at Morehouse College

Hygafem's hand sanitizing program launched at Morehouse College

E. coli pervasive in stream-water with fecal indicator bacteria

E. coli pervasive in stream-water with fecal indicator bacteria

Biochemists are developing a new system to better understand antibiotic resistance

Biochemists are developing a new system to better understand antibiotic resistance

Novel cleavage sites for enzyme caspase-3 identified

Novel cleavage sites for enzyme caspase-3 identified

Bioniche Life Sciences' revenue increases by 21% for the fiscal year 2009

Bioniche Life Sciences' revenue increases by 21% for the fiscal year 2009

Bioniche announces fiscal 2009 year-end results

Bioniche announces fiscal 2009 year-end results

New vaccine may prove effective against urinary tract infections

New vaccine may prove effective against urinary tract infections

Nomir publishes efficacy of the Noveondual-wavelength device against infectious disease pathogens

Nomir publishes efficacy of the Noveondual-wavelength device against infectious disease pathogens

Effective steps to prevent the further spread of E. Coli outbreaks

Effective steps to prevent the further spread of E. Coli outbreaks

Thermo Fisher to showcase food safety solutions at AOAC 2009, Philadelphia

Thermo Fisher to showcase food safety solutions at AOAC 2009, Philadelphia

NovaBay's Aganocide compounds effective against multidrug-resistant bacteria

NovaBay's Aganocide compounds effective against multidrug-resistant bacteria

Phase 1 trial results of Achaogen's ACHN-490 announced at ICAAC meeting

Phase 1 trial results of Achaogen's ACHN-490 announced at ICAAC meeting

Clinical data on CXA-101 to be presented at ICAAC

Clinical data on CXA-101 to be presented at ICAAC

Scarab Genomics and Neoclone sign license agreement

Scarab Genomics and Neoclone sign license agreement

Health care reform should tackle food safety

Health care reform should tackle food safety

Hanson Technologies receives patent for its UltraRapid technology

Hanson Technologies receives patent for its UltraRapid technology

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.